← All stocks

Sarepta Therapeutics, Inc.

SRPT Net selling

CIK 0000873303 #2046 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$417.41K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$417.41K

2 of 2 sales

Net

−$417.41K

−$417.41K against sales at will

By person

16 insiders · 6 transactions

13.5×

Douglas S. Ingram holds 13.5 times base salary in stock. $15.82M of shares against $1.17M in salary for 2025.

Salary from the company's own proxy. The shares are what Douglas S. Ingram last reported holding, valued at $17.02, the price Common Stock was last bought or sold at on the open market here, on 12 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Estepan Ian Michael

Chief Operating Officer

—

$294.20K (1)

−$294.20K

177,184

0.1677%

$3.02M

+422.0%

Mayo Stephen

Director

—

$123.21K (1)

−$123.21K

18,640

0.0176%

$317.25K

+181.5%

Barry Richard

Director

—

2,983,542

2.82%

$50.78M

+1.8%

INGRAM DOUGLAS S

Chief Executive Officer

—

929,391

0.8799%

$15.82M

+138.1%

SEVERINO MICHAEL

Chief Executive Officer

—

756,104

0.7158%

$12.87M

—

BEHRENS M KATHLEEN

Director

—

214,357

0.2029%

$3.65M

+12.2%

Rodino-Klapac Louise

President, R&D and Tech Ops

—

203,900

0.1930%

$3.47M

+181.6%

Wong Ryan Ho-Yan

Chief Financial Officer

—

121,792

0.1153%

$2.07M

+589.8%

Rothfuss Cristin

EVP, General Counsel

—

115,519

0.1094%

$1.97M

+738.4%

Nicaise Claude

Director

—

48,407

0.0458%

$823.89K

+166.4%

Wigzell Hans Lennart Rudolf

Director

—

42,098

0.0399%

$716.51K

+84.3%

Murray Dallan

Chief Customer Officer

—

38,202

0.0362%

$650.20K

+71.9%

Arif Bilal

Chief Tech Ops Officer

—

32,500

0.0308%

$553.15K

+85.6%

Chambers Michael Andrew

Director

—

27,535

0.0261%

$468.65K

+232.7%

Boor Kathryn Jean

Director

—

25,138

0.0238%

$427.85K

+234.5%

Connelly Deirdre P

Director

—

22,100

0.0209%

$376.14K

+677.6%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Estepan Ian Michael

26 Feb 2026

Chief Operating Officer

Exercised, kept

5,381

$13.71

$73.77K

Estepan Ian Michael

26 Feb 2026

Chief Operating Officer

Exercised, kept

2,069

$13.71

$28.37K

Nicaise Claude

29 Jan 2026

Director

Exercised, kept

10,500

$13.71

$143.96K

BEHRENS M KATHLEEN

27 Jan 2026

Director

Exercised, kept

10,500

$13.71

$143.96K

Show all 6 transactions →

Sarepta Therapeutics, Inc.

By person

Individual transactions

What was left out